Acute MI

In 2020, there were 928,741 deaths in the United States due to coronary heart disease (CHD), stroke, and cardiovascular disease (CVD), comprising one-third of all deaths.
- Breakdown of deaths: 41% from CHD, 9% from heart failure (HF), 17% from cerebrovascular accidents (CVA), and others from hypertension (HTN).
Direct and indirect costs of total CVD amounted to $407.3 billion, with $251.4 billion as direct costs and $155.9 billion as lost productivity/mortality.
There were approximately 805,000 new events of MI, with 350,000 recurrences annually.
- Approximately 114,000 will die from MI, with three-quarters of these deaths occurring within one hour of symptom onset.
- Sudden cardiac arrest statistics: only 12% of out-of-hospital cases survive; this doubles for those occurring in hospitals. The community is emphasized as the ultimate coronary care unit (American Heart Association).

Recognized MI rates vary by race, with a higher rate in whites (5.04 per 1000 person-years) versus blacks (3.24 per 1000 person-years).
Median survival post-first MI (≥45 years):
- White males: 8.4 years
- White females: 5.6 years
- Black males: 7.0 years
- Black females: 5.5 years
Socioeconomic factors:
- Individuals reporting low income and education have a twofold incidence of CHD compared to those with high income and education (10.1 versus 5.2 per 1000 person-years).

Key branches and arteries involved:
- Right coronary artery (RCA) including its branches: sinuatrial nodal branch, atrial branch, right marginal branch.
- Left coronary artery (LCA) including: circumflex branch, anterior interventricular branch (left anterior descending).

Atherosclerosis is characterized as a reactive and inflammatory process involving:
- Inflammation and injury
- Activation of monocyte-derived macrophages, leading to the formation of fatty streaks, recruitment of T-cells, and aggregation of other inflammatory cells into atheromas.
- Inflammatory markers: IL-6 and C-reactive protein (CRP) associated with omega-6 fatty acids impact.
- These processes lead to increased plaque volume and instability contributing to myocardial infarction.

Definition of MI:
- Myocardial necrosis consistent with ischemia, with at least one of the following:
- Symptoms indicative of ischemia.
- New or significant ST-segment-T wave changes or new left bundle branch block.
- Development of pathological Q waves on ECG.
- Imaging evidence of new loss of viable myocardium or other abnormalities.
- Identification of thrombus through angiography or autopsy.
Classifications of MI include:
- STEMI (ST-elevation myocardial infarction) vs NSTEMI (non-ST-elevation myocardial infarction).
- Q-wave versus non-Q-wave myocardial infarction (NQWMI).
- Unstable angina and definitions surrounding cardiac arrest.

Background: 44-year-old male undergoing rehabilitation post-rotator cuff repair.
Clinical presentation during PT visit:
- Complaining of heartburn and left shoulder ache, expressing a desire to communicate with supervising clinical instructor (CI).
Actions Taken:
- Decision to avoid upper body ergometer (UBE) and other tolerable exercises, focusing on phonophoresis and joint mobilizations.

After a local diner visit, Fred displayed:
- Pale and diaphoretic appearance with clammy skin.
- He was transported via ambulance to the emergency department (ED); vital signs indicated elevated blood pressure and thready pulse.
- ECG performed on first medical contact (FMC).

Diagnostic Strategies:
- Patients presenting with acute chest pain should undergo ordered tests, with an emphasis on high-sensitivity troponins for detection of cardiac injury.
- Recommendations include seeking early care for acute symptoms, utilizing clinical decision pathways for identifying noncardiac causes, especially concerning accompanying symptoms (particularly in women).
Importance of structured risk assessment for evaluating ongoing testing needs.

Enzymatic changes associated with myocardial infarction:
- Troponin I levels are crucial for diagnosis, with potential increases observed 30x over normal in MI, highlighting specificity in differentiating cardiac from skeletal muscle isomers.
Timing is critical—measurements increase sharply post-symptom onset, necessitating clinical urgency within guidelines for effective intervention.

Guidelines for timely reperfusion therapy:
- Focus on time from symptom onset to balloon angioplasty and assess available medical treatment before deciding on fibrinolysis if percutaneous coronary intervention (PCI) isn't available in due course.
Medications essential during ED management include antiplatelet therapy, beta-blockers, ACE inhibitors, and statins as part of a comprehensive approach within the first 24 hours of admission.

Early post-MI phase I cardiac rehabilitation:
- Emphasizes monitoring exercise tolerance, with protocols established regarding adjustments to patient's physical activity based on hemodynamic stability and risk factors.
Considerations for exercise intensity and response, including perceived exertion ratings.
- Focus on patient education for lifestyle modifications to mitigate future cardiac events, screen for depression, and establish social support networks.
- End goals include achieving optimal patient independence and health management.

Following discharge, patients like Fred should adhere to a structured outpatient cardiac rehab program emphasizing ongoing exercise and dietary modifications.
Regular assessments should evaluate LV function and other health markers pre- and post-rehabilitation.

Comprehensive patient management post-MI encapsulates the integration of symptom recognition, diagnostic assessments, treatment protocols, and long-term lifestyle adaptations to reduce recurrent risks.
Essential components include education, cardiac health literacy improvement, and support systems, leading to better outcomes for patients like Fred.

Continuous research in defining myocardial injury and refining assessment protocols are key areas for ongoing clinical impact in cardiology and rehabilitation fields.